Study of the effect of adding topical Nepafenac 0.1% eye drop on increasing mydriasis in patients with diabetes mellitus type 2: دراسة فعالية إضافة قطرة النيبافيناك الموضعي 0.1% في زيادة توسع الحدقة لدى مرضى الداء السكري النمط 2

Objective: To evaluate the effect of adding topical Nepafenac 0.1% eye drop on increasing mydriasis in patients with Diabetes Mellitus type 2. Methods: study was conducted 73 eyes who had 2 diabetes for 5 years or more. The pupil diameter (PD) measured both without dilation using an Autorefractokeratometer (Grand Seiko\GR- 3500 Ka), then pupils were dilated Tropicamide 1%. A second measurement taken after dilating same device. Topical prescribed 3 times a day days right eye. During review, days, third efficacy evaluated by determining increase that received and comparing it other did not receive. Results: mean 4.68±0.8 mm left 4.67±0.7 (P=0.8). After applying topically 6.50 ± 0.9 5.10± 0.08 (P=0.001). change 1.82 0.7 mm, 0.43 0.6 mm. Conclusion: application showed pupillary 1% mellitus.